Jason T. Goodrich

Statistics

Publications

Citations

255

H-Index

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jason T. Goodrich is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and antiviral structure-activity relationships.

Publications per year

2000–2014

Publications

Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

Makonen Belema, Van N. Nguyen, Carol Bachand et al. · Journal of Medicinal Chemistry · 2014 · 87 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity

Denis R. St. Laurent, Michael H. Serrano‐Wu, Makonen Belema et al. · Journal of Medicinal Chemistry · 2013 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies

Omar D. Lopez, Van N. Nguyen, Denis R. St. Laurent et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 29 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons

Makonen Belema, Van N. Nguyen, J. Romine et al. · Journal of Medicinal Chemistry · 2014 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

Denis R. St. Laurent, Makonen Belema, Min Gao et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 27 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +14

1–5 of 8